Failure of tibolone to control hypoestrogenic symptoms in premenopausal women undergoing hysterectomy and bilateral salpingoophorectomy

By Howell Rosemary   Rose Gillian  

Journal of Obstetrics & Gynaecology, Vol. 17, Iss. 6, 1997-12 ,pp. : 578-579

Informa Healthcare

Access to resources Recommend Favorite

Long-term administration of tibolone plus gonadotropin-releasing hormone agonist for the treatment of uterine leiomyomas: effectiveness and effects on vasomotor symptoms, bone mass, and lipid profiles - influence on markers of cardiovascular disease

By Palomba S.   Affinito P.   Di Carlo C.   Bifulco G.   Nappi C.  

Fertility and Sterility, Vol. 72, Iss. 5, 1999-11 ,pp. : 889-895

Elsevier

Access to resources Recommend Favorite

Long-term follow-up on the treatment of endometriosis with the GnRH-agonist buserelinacetate. Long-term follow-up data (up to 98 months) of 42 patients with endometriosis who were treated with GnRH-agonist buserelinacetate (Suprecur(R)), were evaluated in respect of recurrence of pain symptoms and pregnancy outcome

By Regidor P.-A.   Regidor M.   Kato K.   Bier U.W.   Buhler K.   Schindler A.E.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 73, Iss. 2, 1997-06 ,pp. : 153-160

Elsevier

Access to resources Recommend Favorite

A case report of recurrent endometriosis following Tibolone hormone replacement therapy

By Sundar S. S.   Gornall R. J.   Kerr-Wilson R.   Swingler G. R.   Kinder R. B.   McCarthy K.  

Journal of Obstetrics & Gynaecology, Vol. 27, Iss. 4, 2007-01 ,pp. : 433-434

Informa Healthcare

Access to resources Recommend Favorite

Prediction of the change in bone mineral density induced by gonadotropin-releasing hormone agonist treatment for endometriosis

By Matsuo H.  

Fertility and Sterility, Vol. 81, Iss. 1, 2004-01 ,pp. : 149-153

Elsevier

Access to resources Recommend Favorite